Table 1.

Indication and contraindications for TARE; official status in Switzerland KLV Addendum 9.3. from July 1, 2010

Indication

Inoperable, chemotherapy-refractory liver tumors in which no other local ablative or embolizing therapy is indicated or has been non-effective

Indication through interdisciplinary hepatobiliary center with specialized surgery, interventional radiology

Signed patient consent form

Contraindications

Palpable ascites or other clinical signs of liver failure

Significant laboratory signs of liver failure (ALT, AST > 5 × ULN), bilirubin > 1.5 ULN

Relevant hepato-pulmonary shunt (generally >20%)

Relevant, non-correctable reflux in stomach, duodenum, pancreas, or other intestinal organs

Dominant extrahepatic disease